Alle Storys
Folgen
Keine Story von Eckert & Ziegler Strahlen und Medizintechnik AG mehr verpassen.

Eckert & Ziegler Strahlen und Medizintechnik AG

ots Ad hoc-Service: Eckert & Ziegler AG <DE0005659700> Eckert & Ziegler to Acquire the Worldwide Sources Business from DuPont Pharmaceuticals Company

Berlin (ots Ad hoc-Service) -

The sender is solely responsible for the contents of this
announcement.
Eckert & Ziegler Strahlen- und
Medizintechnik AG WKN 565 970
Eckert & Ziegler to Acquire the Worldwide Sources Business from
DuPont Pharmaceuticals Company
Neue-Markt listed Eckert & Ziegler Strahlen- und Medizintechnik
AG, a leading provider of radioactive components for medical and
industrial applications, has acquired the assets and product
responsibilities of the Worldwide Sources Business from DuPont
Pharmaceuticals Company, Delaware (USA). The agreement, which is
effective on 5 June 2000, covers a large range of radioactive
industrial and nuclear medicine products and will be accompanied,
after a short transition period, by the transfer of the production
technology to Eckert & Ziegler's subsidiaries Isotope Products
Laboratory, Inc. (California) and CESIO s.r.o. (Prague, Czech
Republic). DuPont's sealed source business in 1999 had revenues of
approximately 8 mm US$. Its customer base includes the large
international manufacturers of sophisticated medical measurement
devices.
The acquisition will make the Berlin-based isotope specialist one
of the largest manufacturers for a number of radioactive components,
among them nuclear medicine reference sources and standards. These
items are used by hospitals around the world for the quality control
of their gamma cameras and PET scanners. Eckert & Ziegler is already
a leading developer of a variety of cardio-vascular radiation
sources, which are used for the effective prevention of the
re-narrowing of arteries after balloon dilatations. Apart from these
products, Eckert & Ziegler manufactures radioactive implants and
brachytherapy products for the treatment of cancer. The management of
Eckert & Ziegler expects the acquisition of DuPont's Worldwide Source
Business to result in substantial economies of scale and better
customer service, an increase in revenues, and an improved position
vis-a-vis various raw material suppliers.
The Board of Directors
For further information please contact: 
   Dr. Andreas Eckert CEO and President 
   Eckert & Ziegler AG 
   Robert-Rössle-Str. 10 
   D-13125 Berlin
   Tel.: (+ 49 30) 94 10 84 - 0 
   Fax: (+ 49 30) 94 10 84 - 112
   http://www.ezag.de
End
Internet: http://recherche.newsaktuell.de

Original-Content von: Eckert & Ziegler Strahlen und Medizintechnik AG, übermittelt durch news aktuell

Weitere Storys: Eckert & Ziegler Strahlen und Medizintechnik AG
Weitere Storys: Eckert & Ziegler Strahlen und Medizintechnik AG